Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
hexacétonide de triamcinolone |
Is a |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone diacetate |
Is a |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone acetonide |
Is a |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone adverse reaction |
Causative agent (attribute) |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
hexacétonide de triamcinolone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Allergy to triamcinolone |
Causative agent (attribute) |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Kenalog 80mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone 40mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone 80mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone hexacetonide 5mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone acetate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Product containing chlortetracycline and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing neomycin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing econazole and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing triamcinolone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing triamcinolone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Product containing triamcinolone in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone hexacetonide 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone hexacetonide 20mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone acetonide (substance) |
Is a |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone dental paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Product containing triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone hexacetonide 20mg/mL injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone hexacetonide 5mg/mL injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone 40mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone 80mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone hexacetonide (substance) |
Is a |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Nystatin + triamcinolone acetonide 100000unt/1mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Nystatin + triamcinolone acetonide 100000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Nystatin + triamcinolone acetonide 10000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Injection of triamcinolone for local action |
Direct substance |
False |
Triamcinolone |
Inferred relationship |
Some |
1 |
Injection of triamcinolone into nail bed |
Direct substance |
False |
Triamcinolone |
Inferred relationship |
Some |
1 |
Injection of triamcinolone into keloid scar |
Direct substance |
False |
Triamcinolone |
Inferred relationship |
Some |
1 |
Injection of triamcinolone (procedure) |
Direct substance |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Injection of triamcinolone into keloid scar |
Direct substance |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Injection of triamcinolone into nail bed |
Direct substance |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing triamcinolone in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
|
Product containing triamcinolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing triamcinolone in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
1 |
Injection of triamcinolone (procedure) |
Direct substance |
False |
Triamcinolone |
Inferred relationship |
Some |
1 |
Injection of triamcinolone for local action |
Direct substance |
False |
Triamcinolone |
Inferred relationship |
Some |
1 |
Allergy to triamcinolone |
Causative agent (attribute) |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone hexacetonide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone acetonide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone diacetate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Triamcinolone |
Inferred relationship |
Some |
|
Triamcinolone 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing neomycin and triamcinolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing only chlortetracycline and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing only econazole and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing only neomycin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing only nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing only triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing only triamcinolone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone only product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing only neomycin and triamcinolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Triamcinolone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing only econazole and triamcinolone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |
Product containing econazole and triamcinolone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone |
Inferred relationship |
Some |
1 |